unknown
Stage
1
Investors
About
Immune-Onc Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies that target myeloid cells to treat blood cancers, solid tumors, and autoimmune diseases.
Explore Immune-Onc Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.